Published in BMJ on August 27, 2010
Primary care of children: the unique role of GPs. Br J Gen Pract (2012) 2.76
Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis (2007) 2.35
Increasing short-stay unplanned hospital admissions among children in England; time trends analysis '97-'06. PLoS One (2009) 2.24
Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet (2003) 2.21
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med (2009) 2.16
Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother (2009) 2.05
Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis (2004) 1.91
Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother (2012) 1.86
The new UK antimicrobial resistance strategy and action plan. BMJ (2013) 1.86
Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010. Clin Infect Dis (2013) 1.85
A potential role for daptomycin in enterococcal infections: what is the evidence? J Antimicrob Chemother (2010) 1.77
Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS (2004) 1.67
Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab (2012) 1.61
Added value of PCR-testing for confirmation of invasive meningococcal disease in England. J Infect (2013) 1.58
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med (2012) 1.54
Linezolid-resistant enterococci: report of the first isolates in the United Kingdom. J Antimicrob Chemother (2002) 1.51
Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis (2002) 1.51
A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. J Antimicrob Chemother (2002) 1.35
Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother (2006) 1.35
Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother (2013) 1.34
Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J (2006) 1.33
Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals. J Antimicrob Chemother (2010) 1.28
Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services. AIDS Patient Care STDS (2009) 1.23
Increasing Pneumocystis pneumonia, England, UK, 2000-2010. Emerg Infect Dis (2013) 1.23
Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United kingdom general practice research database. Pediatrics (2009) 1.22
Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother (2013) 1.19
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J (2012) 1.19
Opening the black box of record linkage. J Epidemiol Community Health (2012) 1.16
Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales. PLoS One (2011) 1.16
High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women. AIDS (2010) 1.09
Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study. AIDS (2010) 1.09
Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Clin Infect Dis (2014) 1.08
Assessing the antimicrobial susceptibility of bacteria obtained from animals. Vet Microbiol (2009) 1.06
Evaluating bias due to data linkage error in electronic healthcare records. BMC Med Res Methodol (2014) 1.04
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. Vaccine (2011) 1.02
Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration. Semin Fetal Neonatal Med (2012) 1.01
Using antibiotics responsibly: right drug, right time, right dose, right duration. J Antimicrob Chemother (2011) 1.01
Off-label antibiotic use in children in three European countries. Eur J Clin Pharmacol (2010) 1.00
The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J (2013) 0.99
No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infect Dis (2008) 0.99
Nevirapine use in HIV-1-infected children. AIDS (2003) 0.99
Oral penicillin prescribing for children in the UK: a comparison with BNF for Children age-band recommendations. Br J Gen Pract (2014) 0.96
Improving antibiotic prescribing in neonatal units: time to act. Arch Dis Child Fetal Neonatal Ed (2010) 0.95
Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J Med Virol (2009) 0.94
Haplotype mapping of the bronchiolitis susceptibility locus near IL8. Hum Genet (2003) 0.94
Risk-benefit analysis of restricting antimicrobial prescribing in children: what do we really know? Curr Opin Infect Dis (2010) 0.93
Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals. Arch Dis Child (2014) 0.93
Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda. Pediatr Infect Dis J (2013) 0.93
Reduction in rotavirus disease due to the infant immunisation programme in England; evidence from national surveillance. J Infect (2015) 0.93
Risk-adjusted monitoring of blood-stream infection in paediatric intensive care: a data linkage study. Intensive Care Med (2013) 0.93
Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis. J Infect Dis (2005) 0.91
Significantly increasing hospital admissions for acute throat infections among children in England: is this related to tonsillectomy rates? Arch Dis Child (2012) 0.91
Antibiotic prescribing for upper respiratory infections: European primary paediatricians' knowledge, attitudes and practice. Acta Paediatr (2012) 0.91
Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough? Curr Opin Infect Dis (2012) 0.90
Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat? Curr Opin Infect Dis (2008) 0.89
Steroids fail to down-regulate respiratory syncytial virus-induced IL-8 secretion in infants. Pediatr Res (2002) 0.89
Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods. J Antimicrob Chemother (2004) 0.89
Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J Infect Dis (2003) 0.89
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study. Clin Infect Dis (2012) 0.89
The changing aetiology of paediatric bacteraemia in England and Wales, 1998-2007. J Med Microbiol (2009) 0.89
Changes in the classification and management of skin and soft tissue infections. J Antimicrob Chemother (2010) 0.88
Comparing neonatal and paediatric antibiotic prescribing between hospitals: a new algorithm to help international benchmarking. J Antimicrob Chemother (2012) 0.87
Prevention of respiratory syncytial virus infection in infants. BMJ (2004) 0.86
Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK. Eur J Pediatr (2015) 0.86
Antibiotic Resistance Prevalence in Routine Bloodstream Isolates from Children's Hospitals Varies Substantially from Adult Surveillance Data in Europe. Pediatr Infect Dis J (2015) 0.86
The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000-2009. Pediatr Infect Dis J (2013) 0.85
Continuing impact of infectious diseases on childhood deaths in England and Wales, 2003-2005. Pediatr Infect Dis J (2010) 0.85
Prevalence of nasopharyngeal carriage of pneumococcus in preschool children attending day care in London. Arch Dis Child (2007) 0.85
Managing and preventing outbreaks of Gram-negative infections in UK neonatal units. Arch Dis Child Fetal Neonatal Ed (2013) 0.85
Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss. Arch Dis Child Fetal Neonatal Ed (2014) 0.85
National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the Netherlands. J Antimicrob Chemother (2011) 0.84
The European Union Antibiotic Awareness Day: the paediatric perspective. Arch Dis Child (2008) 0.84
Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr (2014) 0.84
Clinical trials in neonatal sepsis. J Antimicrob Chemother (2013) 0.83
Ganciclovir treatment in children: evidence of subtherapeutic levels. Int J Antimicrob Agents (2011) 0.83
Epidemiology and clinical outcomes of multidrug-resistant, gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period. Pediatr Infect Dis J (2014) 0.83
Improving antibiotic prescribing for children in the resource-poor setting. Br J Clin Pharmacol (2015) 0.83
Aminoglycoside toxicity in neonates: something to worry about? Expert Rev Anti Infect Ther (2014) 0.83
Risk of bloodstream infection in children admitted to paediatric intensive care units in England and Wales following emergency inter-hospital transfer. Intensive Care Med (2014) 0.83
Invasive bacterial and fungal infections in paediatric patients with cancer: incidence, risk factors, aetiology and outcomes in a UK regional cohort 2009-2011. Pediatr Blood Cancer (2014) 0.83
RSV-infected airway epithelial cells cause biphasic up-regulation of CCR1 expression on human monocytes. J Leukoc Biol (2007) 0.82
Isolation and antimicrobial sensitivities of Kluyvera spp. from humans in England, Wales and Northern Ireland, 2005-2006. Int J Antimicrob Agents (2007) 0.82
Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. Expert Rev Anti Infect Ther (2007) 0.82
New antibiotics for paediatric use: a review of a decade of regulatory trials submitted to the European Medicines Agency from 2000--why aren't we doing better? Int J Antimicrob Agents (2013) 0.82
Increasing skin infections and Staphylococcus aureus complications in children, England, 1997-2006. Emerg Infect Dis (2010) 0.82
Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion. J Clin Endocrinol Metab (2002) 0.82
The European Antibiotic Awareness Day. J Antimicrob Chemother (2008) 0.81